Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012-2013
- PMID: 23884344
- PMCID: PMC4604969
Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012-2013
Abstract
During the week of July 2, 2012, the deaths of two pregnant women and one child were reported by household mortality surveillance in Jamam refugee camp, Maban County, Upper Nile State, South Sudan. All were reported to have yellow eyes before death. During July 27-August 3, 2012, three adult males with acute onset jaundice were admitted to the Médecins Sans Frontières (MSF) hospital in Jamam camp; two died within 4 days of admission. The Republic of South Sudan Ministry of Health, United Nations High Commissioner for Refugees (UNHCR), CDC, and humanitarian organizations responded through enhanced case surveillance, a serosurvey investigation, and targeted prevention efforts. As of January 27, 2013, a total of 5,080 acute jaundice syndrome (AJS) cases had been reported from all four Maban County refugee camps (Doro, Gendrassa, Jamam, and Yusuf Batil). Hepatitis E virus (HEV) infection was confirmed in a convenience sample of cases in each camp. A cross-sectional serosurvey conducted in Jamam camp in November 2012 indicated that 54.3% of the population was susceptible to HEV infection. Across all camps, an AJS case-fatality rate (CFR) of 10.4% was observed among pregnant women. The outbreak response has focused on improving safe drinking water availability, improving sanitation and hygiene, conducting active case finding, and optimizing clinical care, especially among pregnant women. Sustaining these improvements, along with strengthening community outreach, is needed to improve outbreak control. Further investigation of the potential role for the newly developed HEV vaccine in outbreak control also is needed.
Figures



References
-
- Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind, placebo controlled, phase 3 trial. Lancet. 2010;376:895–902. - PubMed
-
- World Health Organization. Outbreak surveillance and response in humanitarian emergencies: WHO guidelines for EWARN implementation. Geneva, Switzerland: World Health Organization; 2012. Available at http://whqlibdoc.who.int/hq/2012/who_hse_gar_dce_2012_1_eng.pdf.
-
- Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379:2477–88. - PubMed
-
- United Nations Population Fund, United Nations High Commissioner for Refugees, World Health Organization. Reproductive health in refugee situations: an inter-agency field manual. Geneva, Switzerland: United Nations High Commissioner for Refugees; 1999. Estimating number of pregnant women in the population if total population is 100,000 [Chapter 9, Annex 5]
-
- Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988–97. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous